Latent hazard in pc and bph patients referred to antiandrogens : pc aggressiveness and ne differentiation (CROSBI ID 513069)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Tarle, Marko ; Petek, Tarnik, Iva ; Novosel, Sunčica ; Ahel, Zaky ; Kusić, Zvonko
engleski
Latent hazard in pc and bph patients referred to antiandrogens : pc aggressiveness and ne differentiation
Antiandrogen treatment of BPH often involves finasteride therapy yielding intraprostatic DHT deficiency. We reported that prolonged antiandrogen therapy may provoke the acquisition of neuroendocrine (NE) activity within the prostate. NE differentiation is a risk factor for the development of an aggressive prostate cancer. This study was undertaken to elucidate the cancer development hazard in BPH patients (pts) treated with finasteride.
antiandrogen treatment; BPH patients
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
3648--3649.
2004.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Anticancer Research
0250-7005
Podaci o skupu
International conference of anticancer research (7 ; 2004)
poster
25.10.2004-30.10.2004
Krf, Grčka
Povezanost rada
Temeljne medicinske znanosti, Kliničke medicinske znanosti
